Patents by Inventor Michael T. McCaman

Michael T. McCaman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5187080
    Abstract: Nucleic acid molecules are provided which encode antigenic proteins capable of inducing in a chicken an immune response conferring protection against Eimeria tenella. Expression vectors containing the nucleic acid molecules are also provided. Methods for producing the proteins or antigenic polypeptides having amino acid sequences included within these proteins are also provided.
    Type: Grant
    Filed: January 21, 1992
    Date of Patent: February 16, 1993
    Assignee: Solvay & Cie S.A.
    Inventors: William H. Andrews, Virginia M. Brothers, James G. Files, Irene Kuhn, Michael T. McCaman, Stacey R. Sias, Leland S. Paul, Thomas C. Gore, Karel Z. Newman, Jr., John L. Tedesco
  • Patent number: 5082775
    Abstract: The present invention relates to the isolation and restoration of biological activity to inactive proteins, that is solubilizing, renaturing and restoring activity to proteins which have been partially denatured or inactivated, e.g. during their synthesis in a host cell, such as E. coli, or during isolation. In particular this invention relates to both a means for extracting insoluble eukaryotic proteins from bacteria and to an efficient process for producing active chymosin from an insoluble chymosin precursor isolated from genetically engineered bacteria.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: January 21, 1992
    Assignee: Berlex Laboratories, Inc.
    Inventors: Michael T. McCaman, John F. King
  • Patent number: 4874705
    Abstract: A genomic DNA molecule having the nucleic acid sequence set forth in FIG. 1 and encoding an antigenic protein derived from Eimeria tenella has been isolated. The protein has a molecular weight of about 25,000 daltons and is composed of two polypeptides joined by a disulfide bond. One of the polypeptides is characterized by a molecular weight of about 17,000 daltons and by a blocked N-terminal amino acid and having the amino acid sequence set forth in FIG. 1. The other polypeptide is characterized by a molecular weight of about 8,000 daltons and has the amino acid sequence set forth in FIG. 1.A cDNA molecule encoding the 25,000 dalton polypeptide with a continuous amino acid sequence has been inserted into expression vectors capable of expressing the 25,000 dalton polypeptide directly or as a fused polypeptide. The polypeptides produced are used in vaccines to immunize chickens against infection by Eimeria tenella.
    Type: Grant
    Filed: December 6, 1985
    Date of Patent: October 17, 1989
    Assignee: Solvay & Cie, S.A.
    Inventors: William H. Andrews, Virginia M. Brothers, James G. Files, Irene Kuhn, Michael T. McCaman, Leland S. Paul, Stacey R. Sias, Thomas C. Gore, Karel Z. Newman, Jr., John L. Tedesco